Yahoo
    Shenzhen - Delayed Quote CNY

    PKU HealthCare Corp.,Ltd. (000788.SZ)

    5.04 -0.26 (-4.91%)
    At close: October 30 at 3:04:15 PM GMT+8
    Dividend
    000788.SZ announced a cash dividend of CNY 0.02 with an ex-date of Nov. 3, 2026
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 000788.SZ
    • Previous Close 5.30
    • Open 5.25
    • Bid 5.04 x --
    • Ask 5.05 x --
    • Day's Range 5.04 - 5.32
    • 52 Week Range 4.66 - 7.99
    • Volume 33,472,196
    • Avg. Volume 23,031,897
    • Market Cap (intraday) 3.004B
    • Beta (5Y Monthly) --
    • PE Ratio (TTM) 168.00
    • EPS (TTM) 0.03
    • Earnings Date --
    • Forward Dividend & Yield 0.17 (3.33%)
    • Ex-Dividend Date Nov 3, 2026
    • 1y Target Est --

    PKU HealthCare Corp.,Ltd. engages in the research, development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers anti-infectives, analgesics, psychotropic drugs, digestive system drugs, and cardiovascular drugs; procurement and pharmacy outsourcing; and cancer screening, health management, and treatment services related to healthcare management and care delivery, as well as involved in distribution, retail, and hospital sales of pharmaceuticals, medical devices, and consumables. It also provides ceftriaxone sodium, meropenem, and cefminox sodium for injection; moxifloxacin hydrochloride injection; clindamycin palmitate hydrochloride granules; naphazoline capsules; celecoxib capsules; dextroketoneprofen tablets and capsules; buspirone hydrochloride tablets; and olanzapine tablets. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1993 and is headquartered in Chongqing, China.

    www.pku-hc.com

    789

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about PKU HealthCare Corp.,Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    000788.SZ
    15.26%
    SSE Composite Index (000001.SS)
    9.32%

    1-Year Return

    000788.SZ
    9.79%
    SSE Composite Index (000001.SS)
    9.73%

    3-Year Return

    000788.SZ
    22.14%
    SSE Composite Index (000001.SS)
    19.11%

    5-Year Return

    000788.SZ
    14.90%
    SSE Composite Index (000001.SS)
    1.46%

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      2.29%

    • Return on Assets (ttm)

      3.13%

    • Return on Equity (ttm)

      1.32%

    • Revenue (ttm)

      903.6M

    • Net Income Avi to Common (ttm)

      20.72M

    • Diluted EPS (ttm)

      0.03

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      1.12B

    • Total Debt/Equity (mrq)

      5.34%

    • Levered Free Cash Flow (ttm)

      604.1M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    000756.SZ Shandong Xinhua Pharmaceutical Company Limited
    12.23 +0.66%
    000790.SZ Chengdu huasun technology group Inc. , LTD.
    3.5300 -6.12%
    000766.SZ Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
    13.79 -3.57%
    000739.SZ Apeloa Pharmaceutical Co.,Ltd
    19.37 -0.67%
    000623.SZ Jilin Aodong Pharmaceutical Group Co., Ltd.
    16.84 +2.75%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: